Company profile for Spine BioPharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Spine BioPharma is committed to bringing to market innovative non-surgical, non-opiate therapies to treat degenerative spine related diseases. Our pipeline of therapeutic treatments target the clinical benefits of reducing pain, restoring function and slowing or stopping pathological disease progression. Patients around the world are struggling with debilitating back pain, trying to avoid invasive surgeries and the potential o...
Spine BioPharma is committed to bringing to market innovative non-surgical, non-opiate therapies to treat degenerative spine related diseases. Our pipeline of therapeutic treatments target the clinical benefits of reducing pain, restoring function and slowing or stopping pathological disease progression. Patients around the world are struggling with debilitating back pain, trying to avoid invasive surgeries and the potential of opioid addiction. Spine Biopharma has developed a non-surgical solution that will remove pain and restore functionality, without having to use opioids.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
505 Park Avenue, 14th Floor, New York, NY 10022
Telephone
Telephone
(212) 583-9700
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/spine-biopharma-misses-primary-endpoint-back-pain-phase-3-blames-sham-response-rate

FIERCE BIOTECH
02 Aug 2025

https://www.businesswire.com/news/home/20250304403612/en

BUSINESSWIRE
04 Mar 2025

https://www.businesswire.com/news/home/20250107142335/en

BUSINESSWIRE
07 Jan 2025

https://www.businesswire.com/news/home/20241121248220/en

BUSINESSWIRE
21 Nov 2024

https://www.businesswire.com/news/home/20240924321228/en

BUSINESSWIRE
24 Sep 2024

https://www.prnewswire.com/news-releases/spine-biopharma-inc-announces-agreement-with-ensol-biosciences-inc-to-expand-indications-for-sb-01-for-injection-302192695.html

PR NEWSWIRE
10 Jul 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty